27,834-share proposed sale by Maplight Therapeutics (NASDAQ: MPLT)

Rhea-AI Filing Summary

Maplight Therapeutics, Inc. filed a Form 144 reporting a proposed sale of 27,834 shares of Common stock. The filing lists prior sales by Kris Hanson of 1,529 shares on 04/15/2026 for $40,974.77 and 298 shares on 04/16/2026 for $8,156.77.

Key Figures

Proposed sale: 27,834 shares Recent sale (K. Hanson): 1,529 shares Recent sale (K. Hanson): 298 shares +1 more

4 metrics

Proposed sale 27,834 shares Common stock listed on Form 144

Recent sale (K. Hanson) 1,529 shares Sold on 04/15/2026 for $40,974.77

Recent sale (K. Hanson) 298 shares Sold on 04/16/2026 for $8,156.77

Reported amount $854,503.80 Amount appearing in filing excerpt

Key Terms

Form 144, Vested RSU, Securities To Be Sold

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Vested RSU financial

"Common | 07/05/2024 | Vested RSU"

Securities To Be Sold regulatory

"144: Securities To Be Sold"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Jefferies LLC 520 Madison Avenue 4th Floor New York NY 10022	27834	854503.80	42000000	05/04/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/05/2024	Vested RSU	Maplight Therapeutics, Inc.			27834	07/05/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kris Hanson 800 Chesapeake Drive Redwood City CA 94063	Maplight Therapeutics, Inc.	04/15/2026	1529	40974.77
Kris Hanson 800 Chesapeake Drive Redwood City CA 94063	Maplight Therapeutics, Inc.	04/16/2026	298	8156.77

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Maplight Therapeutics (MPLT) Form 144 report?

The filing reports a proposed sale of 27,834 shares of Common stock. It also records two recent disposals by Kris Hanson of 1,529 and 298 shares on 04/15/2026 and 04/16/2026.

Who sold shares recently according to the Form 144 for MPLT?

The filing identifies Kris Hanson as a selling party. Hanson sold 1,529 shares on 04/15/2026 and 298 shares on 04/16/2026, with proceeds shown in the filing.

How much cash did the recent sales generate in the Form 144?

The Form 144 lists proceeds of $40,974.77 for the 1,529-share sale and $8,156.77 for the 298-share sale. Those amounts appear alongside the respective sale dates in the filing.

Does the Form 144 show the type of securities being sold for MPLT?

Yes. The filing categorizes the securities as Common stock issued upon a Vested RSU award dated 07/05/2024. The proposed sale quantity is presented as 27,834 shares in the filing.